BRADIKANT 30 MG/3 ML SOLUTION FOR S.C. INJECTION IN PRE-FILLED SYRINGE

BRADIKANT 30 MG/3 ML SOLUTION FOR S.C. INJECTION IN PRE-FILLED SYRINGE
Product Description

BRADIKANT is indicated for symptomatic treatment of acute attacks of hereditary
angioedema (HAE) in adults, adolescents and children aged 2 years and older, with C1-esterase-inhibitor deficiency.

Polifarma

  • Country/Region:
    Türkiye
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Animal Health
Finished Formulation products Distributor/Buyer
Laboratory, Analytical, Biotechnology Equipment
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution

Polifarma

  • Country/Region:
    Türkiye
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Animal Health
Finished Formulation products Distributor/Buyer
Laboratory, Analytical, Biotechnology Equipment
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution

More Products from Polifarma (60)

Polifarma resources (2)